These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 18634509

  • 1. Canine adenovirus based rabies vaccines.
    Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M.
    Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
    [Abstract] [Full Text] [Related]

  • 2. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B.
    Virology; 2008; 356(1-2):147-54. PubMed ID: 16938327
    [Abstract] [Full Text] [Related]

  • 3. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein.
    Hu R, Zhang S, Fooks AR, Yuan H, Liu Y, Li H, Tu C, Xia X, Xiao Y.
    Microbes Infect; 2006 Apr; 8(4):1090-7. PubMed ID: 16524754
    [Abstract] [Full Text] [Related]

  • 4. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S, Liu Y, Fooks AR, Zhang F, Hu R.
    Vaccine; 2008 Jan 17; 26(3):345-50. PubMed ID: 18083277
    [Abstract] [Full Text] [Related]

  • 5. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.
    Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, Dubois E, Thiery R, Bréard E, Tordo N, Richardson J, Schwartz-Cornil I, Zientara S, Klonjkowski B.
    Vaccine; 2011 Feb 01; 29(6):1304-10. PubMed ID: 21134446
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N, Jackson FR, Niezgoda M, Ellison JA, Rupprecht CE, Nel LH.
    Vaccine; 2013 Aug 28; 31(38):4177-82. PubMed ID: 23867013
    [Abstract] [Full Text] [Related]

  • 7. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR.
    Vaccine; 2007 Jul 20; 25(29):5301-7. PubMed ID: 17576027
    [Abstract] [Full Text] [Related]

  • 8. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S, Chaturvedi VK, Rai A, Saini M, Chandra R, Saini Y, Gupta PK.
    Vaccine; 2007 May 16; 25(20):4020-8. PubMed ID: 17391817
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y, Zhang S, Ma G, Zhang F, Hu R.
    Vaccine; 2008 Oct 03; 26(42):5368-72. PubMed ID: 18721839
    [Abstract] [Full Text] [Related]

  • 10. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M, Saxena A, Rai A, Bhatnagar R.
    FASEB J; 2010 Jan 03; 24(1):173-83. PubMed ID: 19741168
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
    Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK.
    Virus Res; 2005 Nov 03; 113(2):143-52. PubMed ID: 15978691
    [Abstract] [Full Text] [Related]

  • 12. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH, Zhang Y, Wang SH, Liu L, Yang F.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec 03; 25(6):650-4. PubMed ID: 14714304
    [Abstract] [Full Text] [Related]

  • 13. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
    Wang YZ, Zhang SF, Hu RL, Wang X, Xiao YQ.
    Wei Sheng Wu Xue Bao; 2005 Apr 03; 45(2):213-7. PubMed ID: 15989263
    [Abstract] [Full Text] [Related]

  • 14. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E, Hernández González R, Alonso Morales R, Aguilar-Setién A.
    Dev Biol (Basel); 2006 Apr 03; 125():221-31. PubMed ID: 16878480
    [Abstract] [Full Text] [Related]

  • 15. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ, Yang Y, Wilson JM, Ertl HC.
    Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532
    [Abstract] [Full Text] [Related]

  • 16. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W, Zhang Y, Wang S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar 01; 15(1):61-5. PubMed ID: 12526306
    [Abstract] [Full Text] [Related]

  • 17. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL, Ewalt LC, Parnell MJ, Rupprecht CE, Hanlon CA.
    Vaccine; 2006 Jan 23; 24(4):412-6. PubMed ID: 16153757
    [Abstract] [Full Text] [Related]

  • 18. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S, Dahiya SS, Sonwane AA, Patel CL, Saini M, Rai A, Gupta PK.
    Vaccine; 2008 Dec 02; 26(51):6592-601. PubMed ID: 18848857
    [Abstract] [Full Text] [Related]

  • 19. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine.
    Henderson H, Jackson F, Bean K, Panasuk B, Niezgoda M, Slate D, Li J, Dietzschold B, Mattis J, Rupprecht CE.
    Vaccine; 2009 Nov 27; 27(51):7194-7. PubMed ID: 19925952
    [Abstract] [Full Text] [Related]

  • 20. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
    Osinubi MO, Wu X, Franka R, Niezgoda M, Nok AJ, Ogunkoya AB, Rupprecht CE.
    Vaccine; 2009 Nov 27; 27(51):7214-8. PubMed ID: 19925956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.